Emily Liffick

  • Assistant Professor of Clinical Psychiatry, Psychiatry
  • 124 Citations
  • 5 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Emily Liffick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Psychotic Disorders Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Cognition Medicine & Life Sciences
Episodic Memory Medicine & Life Sciences
Transcranial Magnetic Stimulation Medicine & Life Sciences
Migraine Disorders Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
Health Services Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2010 2019

  • 124 Citations
  • 5 h-Index
  • 10 Article
  • 1 Review article

Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat

Willis, B. A., Andersen, S. W., Ayan-Oshodi, M., James, D. E., Liffick, E., Hillgren, K., Guo, Y. & Monk, S. A., Jan 1 2019, (Accepted/In press) In : Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Drug Interactions
Breast Neoplasms
Proteins
Area Under Curve
Rosuvastatin Calcium

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

Krege, J. H., Rizzoli, P. B., Liffick, E., Doty, E. G., Dowsett, S. A., Wang, J. & Buchanan, A. S., Jul 1 2019, In : Cephalalgia. 39, 8, p. 957-966 10 p.

Research output: Contribution to journalArticle

Migraine Disorders
Safety
Placebos
Therapeutics
Hypesthesia
3 Citations (Scopus)

Cognitive effects of bilateral high frequency repetitive transcranial magnetic stimulation in early phase psychosis: a pilot study

Francis, M. M., Hummer, T. A., Vohs, J., Yung, M. G., Visco, A. C., Mehdiyoun, N. F., Kulig, T. C., Um, M., Yang, Z., Motamed, M., Liffick, E., Zhang, Y. & Breier, A., May 31 2018, (Accepted/In press) In : Brain Imaging and Behavior. p. 1-10 10 p.

Research output: Contribution to journalArticle

Transcranial Magnetic Stimulation
Psychotic Disorders
Schizophrenia
Therapeutics
Treatment-Resistant Depressive Disorder
9 Citations (Scopus)

Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders

Breier, A., Liffick, E., Hummer, T. A., Vohs, J., Yang, Z., Mehdiyoun, N. F., Visco, A. C., Metzler, E., Zhang, Y. & Francis, M. M., Jan 1 2018, (Accepted/In press) In : Schizophrenia Research.

Research output: Contribution to journalArticle

Cognition
Cysteine
Schizophrenia
Brain
Placebos
7 Citations (Scopus)

Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814)

Sims, J. R., Selzler, K. J., Downing, A. M., Willis, B. A., Aluise, C. D., Zimmer, J., Bragg, S., Andersen, S., Ayan-Oshodi, M., Liffick, E., Eads, J., Wessels, A. M., Monk, S., Schumi, J. & Mullen, J., Jan 1 2017, In : The journal of prevention of Alzheimer's disease. 4, 4, p. 247-254 8 p.

Research output: Contribution to journalReview article

Alzheimer Disease
Serum Amyloid A Protein
Phase III Clinical Trials
Amyloid beta-Protein Precursor
4-methoxy-5'-methyl-6'-(5-(prop-1-yn-1-yl)pyridin-3-yl)-3'H-dispiro(cyclohexane-1,2'-inden-1',2'-imidazol)-4'-amine